Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 17, 2025
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications
GlobeNewswire
·
April 17, 2025
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …
Atana Recognized for Innovation and Technology in Ragan’s 2025 Employee Communications Awards
GlobeNewswire
·
April 17, 2025
BELLEVUE, Wash., April 17, 2025 (GLOBE NEWSWIRE) -- Seeking to redefine workplace culture and training, Atana is proud to announce that it has been named a winner in Ragan’s Employee Communications Awards. The Innovation and Technology Award for HR Tool/ …
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
GlobeNewswire
·
April 17, 2025
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness …
Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
GlobeNewswire
·
April 17, 2025
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …
Eros Resources Announces Approval of Name Change and Share Consolidation
GlobeNewswire
·
April 17, 2025
Vancouver, BC, April 17, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV: ROCK) (OTCQB: EROSF) (“Eros” or the “Company”) announces the official consolidation of its common shares on the basis of a ten (10) pre-consolidation shares for one (1) new post- …
Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions
GlobeNewswire
·
April 17, 2025
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in …
Cryptocurrency trends and policies are connected, SIX MINING stands at the "new outlet"
GlobeNewswire
·
April 17, 2025
London, UK, April 17, 2025 (GLOBE NEWSWIRE) -- If El Salvador is integrating the country into the Bitcoin ecosystem through policy means, then SIX MINING represents the civil power of cryptocurrency technology application. The platform not only deploys …
Signing Day Sports/U.S. Army Bowl Combines Provide Recruitment Opportunities, Draw Strong Participation
GlobeNewswire
·
April 17, 2025
SCOTTSDALE, AZ, April 17, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform, today provided an in-season update on the 2025 Military …
Interius BioTherapeutics to Present at Upcoming Scientific Meetings
GlobeNewswire
·
April 17, 2025
PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Interius BioTherapeutics, a clinical-stage company engineering targeted, programmable vectors for the precision delivery of genetic medicines, today announced that it will present at several upcoming …
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
GlobeNewswire
·
April 17, 2025
Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos’ ZELSUVMI™ ZELSUVMI is an FDA-designated novel drug and the first and only prescription medication approved …
Precore Gold Announces Appointment of Louis Gariepy to Its Advisory Board
GlobeNewswire
·
April 17, 2025
VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce the appointment of Mr. Louis Gariepy, P. Eng (OIQ) to its Advisory Board as Lead Technical Advisor. Mr. …
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
GlobeNewswire
·
April 17, 2025
VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Ragnarok: Back to Glory Official Launching in Korea and Southeast Asia on April 17, 2025
GlobeNewswire
·
April 17, 2025
Seoul, South Korea, April 17, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced the official launch of Ragnarok: Back to Glory, in Korea and Southeast Asia …
Verano Elevates Florida Retail Footprint to 81 Dispensaries with the Opening of MÜV New Smyrna Beach
GlobeNewswire
·
April 17, 2025
Dispensary to celebrate 420 “high holiday” opening weekend with plethora of deals and discounts available at all Florida MÜV locations Located at 763 East 3rd Avenue, MÜV New Smyrna Beach is Verano’s fourth MÜV location in Florida’s Volusia County, a …
Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors
GlobeNewswire
·
April 17, 2025
The Shareholders’ Committee of Boehringer Ingelheim have announced the following appointments in the Shareholders’ Committee and the Board of Managing Directors: Christian Boehringer, since 2007 Chairman of the Shareholders’ Committee, has decided to step …
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
GlobeNewswire
·
April 17, 2025
ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical …
BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs
GlobeNewswire
·
April 17, 2025
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the April 2025 cash distributions for the iShares ETFs listed …
FLYR Hospitality to Power Business Intelligence for Ennismore
GlobeNewswire
·
April 17, 2025
SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- FLYR, the technology company that unlocks freedom to innovate for the travel industry, today announced that Ennismore, the fastest-growing lifestyle and leisure hospitality company, is working with FLYR …
Pioneering Swiss Law Firm OBERSON ABELS Goes Live on iManage Cloud
GlobeNewswire
·
April 17, 2025
CHICAGO, April 17, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced that leading Swiss law firm OBERSON ABELS SA has successfully gone live on iManage Cloud, becoming the first Swiss law firm to adopt …